small molecule

AGGRASTAT

TIROFIBAN HYDROCHLORIDE

Loss of exclusivityloss of exclusivity
CompanyMEDICURE INTERNATIONAL INC

Drug detail

Brand nameAGGRASTAT
Active ingredientTIROFIBAN HYDROCHLORIDE
StrengthEQ 12.5MG BASE/50ML (EQ 0.25MG BASE/ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalMay 1998
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

AGGRASTAT patent cliff — loss of exclusivity — | CliffBio